GB202006376D0 - Recombinant sars-cov-2 polypeptides and uses - Google Patents
Recombinant sars-cov-2 polypeptides and usesInfo
- Publication number
- GB202006376D0 GB202006376D0 GBGB2006376.4A GB202006376A GB202006376D0 GB 202006376 D0 GB202006376 D0 GB 202006376D0 GB 202006376 A GB202006376 A GB 202006376A GB 202006376 D0 GB202006376 D0 GB 202006376D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cov
- polypeptides
- recombinant sars
- sars
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2006376.4A GB202006376D0 (en) | 2020-04-30 | 2020-04-30 | Recombinant sars-cov-2 polypeptides and uses |
PCT/IB2021/053641 WO2021220246A1 (en) | 2020-04-30 | 2021-04-30 | Recombinant sars-cov-2 polypeptides and uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2006376.4A GB202006376D0 (en) | 2020-04-30 | 2020-04-30 | Recombinant sars-cov-2 polypeptides and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202006376D0 true GB202006376D0 (en) | 2020-06-17 |
Family
ID=71080558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2006376.4A Ceased GB202006376D0 (en) | 2020-04-30 | 2020-04-30 | Recombinant sars-cov-2 polypeptides and uses |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202006376D0 (en) |
WO (1) | WO2021220246A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111778271A (en) * | 2020-07-21 | 2020-10-16 | 梁建国 | Recombinant plasmid and recombinant bacterium for expressing SARS-CoV-2N protein, construction method and application |
CN113817028A (en) * | 2020-09-22 | 2021-12-21 | 青岛海洋生物医药研究院 | Polypeptide formulations |
WO2022216895A1 (en) * | 2021-04-09 | 2022-10-13 | University Of Florida Research Foundation, Incorporated | Methods, kits, and approaches for viral vaccines |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117651773A (en) | 2021-05-10 | 2024-03-05 | 开普敦大学 | Integrated molecules and glycoengineering of complex viral glycoproteins |
WO2023101007A1 (en) * | 2021-12-03 | 2023-06-08 | 株式会社 アイロムグループ | Antigen-protein expression vector and utilization thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3031822A1 (en) * | 2014-12-08 | 2016-06-15 | Novartis AG | Cytomegalovirus antigens |
US10960070B2 (en) * | 2016-10-25 | 2021-03-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion coronavirus spike proteins and their use |
GB201708866D0 (en) | 2017-06-02 | 2017-07-19 | Univ Cape Town | Expression of chaperone proteins in planta for increased expression of heterologous polypeptides of interest |
GB2573791A (en) | 2018-05-17 | 2019-11-20 | Univ Cape Town | Stabilised superoxide dismutase (SOD) homolog gene and uses thereof |
-
2020
- 2020-04-30 GB GBGB2006376.4A patent/GB202006376D0/en not_active Ceased
-
2021
- 2021-04-30 WO PCT/IB2021/053641 patent/WO2021220246A1/en active Application Filing
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111778271A (en) * | 2020-07-21 | 2020-10-16 | 梁建国 | Recombinant plasmid and recombinant bacterium for expressing SARS-CoV-2N protein, construction method and application |
CN113817028A (en) * | 2020-09-22 | 2021-12-21 | 青岛海洋生物医药研究院 | Polypeptide formulations |
WO2022216895A1 (en) * | 2021-04-09 | 2022-10-13 | University Of Florida Research Foundation, Incorporated | Methods, kits, and approaches for viral vaccines |
Also Published As
Publication number | Publication date |
---|---|
WO2021220246A1 (en) | 2021-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202006376D0 (en) | Recombinant sars-cov-2 polypeptides and uses | |
IL284633A (en) | Polypeptides comprising modified il-2 polypeptides and uses thereof | |
IL304469A (en) | Reprogrammable tnpb polypeptides and use thereof | |
IL287781A (en) | Clec12a-binding polypeptides and uses thereof | |
IL287782A (en) | Cd33-binding polypeptides and uses thereof | |
GB202011652D0 (en) | Polypeptide panels and uses thereof | |
IL288610A (en) | Recombinant fap binding proteins and their use | |
IL280808A (en) | Ox40-binding polypeptides and uses thereof | |
GB202007441D0 (en) | Polypeptide | |
GB201819200D0 (en) | Polypeptide and uses thereof | |
GB202017649D0 (en) | Polypeptide | |
GB2603645B (en) | Polypeptides having anti-senescent effects and uses thereof | |
EP4081241A4 (en) | Regenerative polypeptides and uses thereof | |
GB202201001D0 (en) | Polypeptide and use thereof | |
EP3663313A4 (en) | N-terminal recombinant protein of ccr4 and usage thereof | |
GB202012804D0 (en) | Agrin polypeptide and uses thereof | |
GB202019817D0 (en) | Ligand-binding polypeptides and uses thereof | |
IL275241A (en) | Engineered o-glycosylation in recombinant polypeptides and uses thereof | |
SG11202109015TA (en) | Integrated and continuous recombinant protein manufacturing | |
GB202109082D0 (en) | Polypeptides and uses thereof | |
GB202018733D0 (en) | Polypeptides and uses thereof | |
IL304183A (en) | Actinohivin variant polypeptides and related methods | |
IL309885A (en) | Alpha-sheet polypeptides and their use | |
GB202100996D0 (en) | Ezrin-derived peptides and uses | |
GB202304356D0 (en) | Peptides and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |